Histories of medicine

W. Screiber and F. K. Mathys. Infectious Diseases in the History of Medicine. Kreis and Co., Basel, 1987. 

Johns Hopkins University. Institute of the History of Medicine. Publications (2nd Series) Vol. 1)... 

Wellcome Institute for the History of Medicine. High matter, dark language the philosophy of Robert Fludd (1547-1637). An exhibition at the Wellcome Institute for the History of Medicine. Wellcome Institute. London. London . ... 

Lakshminarayana, Kodali. A History of medicine, surgery, and alchemy in India. Tenali PandurangaP, 1970. ii, 56 p. 

Mahdihassan, S. Indian alchemy or Rasayana in the light of asceticism and geriatrics. New Delhi Institute of History of Medicine and Medical Research, 1977. x, 139 p... 

Workshop on Rasashastra, 24th January 1992 souvenir organised by Indian Institute of History of Medicine, Hyderabad, Central Council for Research in Ayurveda Siddha, Ministry of Health Family Welfare, Govt, of India, New Delhi. Hyderabad The Institute, 1992 122p. 

Recent dissertations in the history of medicine. J Hist Med Allied Sci 58 (Jan... 

Ackerknecht, E. H. A short history of medicine. Baltimore (MD) Johns Hopkins UnivP, 1982. 

Magner, Lois N. A history of medicine. 2nd ed ed. Taylor Francis, 2005. 632p. ISBN 0-8247-4074-2... 

Sigerist, H.E. The great doctors, a biographical history of medicine. New York Doubleday, 1958. 

Revised paper for conference, The rising dawn - the contribution of alchemy to medieval medicine and intellectual life. Wellcome Unit for the History of Medicine University of East Anglia, 21-22 March 2002... 

Lois N. Magner. A History of Medicine. New York Marcel Dekker Inc., 1992. 

Gaines M. Foster. Typhus Disaster in the Wake of War The American-Polish Relief Expedition, 1919-1920. Bulletin of the History of Medicine. 55 (1981) 221-232. 

Because of the power of the placebo effect, almost anything that is believed in seems to work for some types of medical problems. That is why the late Arthur K. Shapiro described the history of medicine as largely the history of the placebo effect.4 It is also why clinical experience alone cannot tell us whether a particular physical substance is an effective treatment. Placebo-controlled trials are required to demonstrate drug efficacy before drugs are approved for marketing. 

If the chemical-imbalance theory is wrong, and if depression is not a brain disease, how is it produced and how can it be prevented and treated One way to look for clues is to examine the process by which we were misled into the realm of chemistry. There is a culprit hiding in the history of the chemical-imbalance theory - a culprit that is guilty of leading doctors and patients astray over and over again in the history of medicine. The culprit is the placebo effect, and its darker twin, the nocebo effect. Depressed people got better when given MAO and reuptake inhibitors as antidepressants, and this led researchers to conclude that depression must be caused by a chemical deficiency. But much (if not all) of that improvement turns out to be a placebo effect. So to understand depression and how it might be treated effectively, we need to examine the placebo effect more carefully. That is the topic of the next two chapters. 

Kaptchuk, Ted J., Intentional Ignorance A History of Blind Assessment and Placebo Controls in Medicine , Bulletin of the History of Medicine 72, no. 3 (1998a) 389-433... 

Libby, W. (1922), History of Medicine, in its Salient Features, Houghton Mifflin, Boston, MA. 

Feldman, S. and Tauber, A. I. (1997), Sickle cell anemia Redefining the first molecular disease Bulletin of the History of Medicine, 71, 623-650. 

Galaty, D. H. (1974), The philosophical basis for mid-nineteenth century German reductionism , Journal of the History of Medicine and Allied Sciences, 29, 295-316. 

BioPrint is particularly useful in placing the new drug candidates in the context of drugs and related compounds that together make up the history of medicinal chemistry. New candidates are run on the same assays as the BioPrint compounds and the resulting profile is analyzed. Profiles can be analyzed in two different ways each individual hit can be analyzed and assessed for potential ADR liabilities or the entire profile can be used to identify compounds with similar profiles. Potential ADR liabilities are assessed based on those of the similar compounds identified. These two different approaches will be discussed in the following sections. 

This publication was supported in part by NIH Grant LM 03300 from the National Library of Medicine. I wish to thank the following for permission to use archival materials Special Collections, Robert W. Woodruff Library, Emory University Alan Mason Chesney Archives, Johns Hopkins University and Division of Archives, State Historical Society of Wisconsin. Part of the research for this paper was carried out while the author was a Visiting Associate Professor at The Johns Hopkins Institute of the History of Medicine. A preliminary, abbreviated version of the paper was delivered at the American Chemical Society meeting in Washington, D.C., on September 12, 1979, at a session of papers in honor of Aaron J. Ihde sponsored by the Division of History of Chemistry. 

NLM Online Exhibitions Describes "Exhibitions in the History of Medicine" httpvywww.nlm.nih.gov/exhibition/exhibition.html. Additional resources for historical scholarship in medicine httpVwww-nlm.nih.gov/hmd/index.html... 

In many developing countries of the world, there is still a major reliance on crude drug preparation of plants used in traditional medicines for their primary health care. Pharmacognosists employed in the different institutions are aware of the changing trends of herbal medications and a number of useful texts on the analysis, uses, and potential toxicities of herbal remedies have appeared recently, which serves as useful guides in pharmacy practice. The history of medicine includes many ludicrous therapies. Nevertheless, ancient wisdom has been the basis of modem medicine and will remain as one important source of future medicine and therapeutics. The future of natural products drug discovery will be more holistic, personahzed and involve the wise use of ancient and modem therapeutic skills in a complementary manner so that maximum benefits can be accmed to the patients and the community. 

---